Skip to main content
logo
XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.640
-0.070 (-2.58%)
At close: Jan 28, 2026, 4:00 PM EST
2.679
+0.039 (1.46%)
After-hours: Jan 28, 2026, 4:16 PM EST

Company Description

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.

It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation.

The company was incorporated in 2005 and is headquartered in Austin, Texas.

XBiotech Inc.
XBiotech logo
CountryUnited States
Founded2005
IPO DateApr 15, 2015
IndustryBiotechnology
SectorHealthcare
Employees88
CEOSushma Shivaswamy

Contact Details

Address:
5217 Winnebago Lane
Austin, Texas 78744
United States
Phone512 386 2900
Websitexbiotech.com

Stock Details

Ticker SymbolXBIT
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001626878
CUSIP Number98400H102
ISIN NumberCA98400H1029
SIC Code2834

Key Executives

NamePosition
Dr. Sushma Shivaswamy Ph.D.Interim Chief Executive Officer and Chief Scientific Officer
John SimardFounder and Chairman
Angela HuDirector of Finance

Latest SEC Filings

DateTypeTitle
Jan 23, 2026SCHEDULE 13G/AFiling
Jan 23, 2026SCHEDULE 13G/AFiling
Dec 9, 20258-KCurrent Report
Nov 12, 202510-QQuarterly Report
Oct 15, 20258-K/A[Amend] Current report
Oct 3, 20258-KCurrent Report
Sep 2, 20258-KCurrent Report
Aug 13, 202510-QQuarterly Report
Jul 7, 2025ARSFiling
Jul 7, 2025DEF 14AOther definitive proxy statements
View All SEC Filings